Relevance of
Intellectual
Property |
|
Intellectual
Property is like any other property and the developed
countries respect and comply with Intellectual Property
India has to do the same. Historically, India was the
seat of knowledge and wisdom, and India was the leader
in most disciplines. Nalanda and Takshila were the seats
of wisdom...
More Details...
|
|
INTERNATIONAL |
|
Non-Regulated
(SOUTH EAST, ASIA, AFRICA, LATIN
AMERICA, CIS ETC)
|
|
| |
|
|
| |
|
|
|
ONCOLOGY API'S & FORMULATIONS
MANUFACTURED BY KLAB
Anastrozole,Bicalutamide,Bortezomib,Capecitabine,Cisplatin,
Cyclophosphamide,Carboplatin,Erlotinib,Gefitinib,Gemcitabine,
Hydroxyurea,Imatinib,Letrozole,Methotrexate,Tamoxifen & Zoledronic .
ONCOLOGY FORMULATIONS
MANUFACTURED BY KLAB
Bleomycin,Docetaxal,Doxorubicin,Epirubicin,Etoposide,Fluorouracil,
Irinotecan,Oxaliplatin,Paclitaxel, Pemetrexed,Temozolomide & Vincristine.
NICHE API's
MANUFACTURED BY KLAB
Camylofin Dihydrochloride, Doxapram Hydrochloride, Glycopyrrolate, Isocarboxazid, Leflunomide, Modafinil, Otilonium bromide.
Klab is having formulation & API dossiers available both in CTD as well as country specific formats.The API documents available are equivalent to CTD(Europe),DMF(US) standards subject to site approval. KLAB has got WHO GMP/cGMP/ISO14001/ISO9001/GLP certifications
Intellectual Property
Nano Silver Gel -
KLAB has received Drugs Controller General of India approval for
its Nano silver gel for manufacturing and marketing in India for
burns,cuts and wounds. Klab has also got a product patent granted for
India..
KLAB has given Hetero non exclusive marketing rights for India.
KLAB has been granted a product & process patent for the following
products:
Cefixime+Cloxacillin+Lactobacillus,
Cefixime O.D.& Cefixime with Flavinoid.KLAB has a patent pending with Dicloxacillin.KLAB also has patents for
these combinations internationally.
Methocarbamol (Skeletal Muscle Relaxant) -
Methocarbamol with Nimesulide tablet, Diclofenac tablet,
Nimsulide dispersible tablet and Diclofenac gel.
Prenoxidiazine Tablet (Anti tussive).
Glycopyrrolate tablets.
Etoricoxib and Paracetamol tablets.
Methotrexate Gel.
KLAB is manufacturing formulations since 1945
KLAB’s Oncology formulations and factory (Mumbai) are registered in-
Zambia, Kenya, Nigeria, Niger, Malawi, Mali, Burkina Faso, Thailand, Myanmar, Philippines, Srilanka, Bhutan, Iran & Pakistan .
Registrations are pending in - Bahamas, Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Jamaica, Nicaragua, Panama, Paraguay, Peru, Trinidad & Tobago, Uruguay, Venezuela
more...
KLAB’s general oral products facility (Uttaranchal, near .Delhi) is registered in Mongolia, Hong Kong, Bhutan, Srilanka, Cambodia, Vietnam, Philippines, Myanmar, Thailand, Honduras, Mozambique, Nigeria & Kenya.
more...
KLAB is supplying Onco API’s to Indonesia, Canada, Bangladesh, Switzerland, Pakistan, Australia,New Zealand, Turkey, Germany, Korea, Cyprus & Denmark
. more...
KLAB is manufacturing Oncology formulations for M/S Ranbaxy, M/S Biochem (Zydus), M/S Hetero, M/S Glenmark , M/s Cadila , M/s Wockhardt , M/S Emcure & M/S Zuventis,
etc.. .
K-CHIRAL’S.
KLab has developed multifunctional Chiral Pools of
Carbohydrates, Monosaccharides, Amino Alcohols, Oxazolidinones etc
K-Dendrimers.
KLab is developing an
economical dendrimer system for cosmetic applications and drug
delivery.
KLab has filed for several patents using dendrimers as a delivery platform.
K-NDDS
KLab has filed several
patents for site specific deliveries
|
|
